Information for "Protection Account along with Adverse Era of Unique Interest pertaining to Fruquintinib throughout China Patients with Previously Treated Metastatic Intestinal tract Cancer malignancy Research Phase Three or more FRESCO Tryout"
From EECH Central
Basic information
Display title | Protection Account along with Adverse Era of Unique Interest pertaining to Fruquintinib throughout China Patients with Previously Treated Metastatic Intestinal tract Cancer malignancy Research Phase Three or more FRESCO Tryout |
Default sort key | Protection Account along with Adverse Era of Unique Interest pertaining to Fruquintinib throughout China Patients with Previously Treated Metastatic Intestinal tract Cancer malignancy Research Phase Three or more FRESCO Tryout |
Page length (in bytes) | 4,014 |
Page ID | 1396029 |
Page content language | English (en) |
Page content model | wikitext |
Indexing by robots | Allowed |
Number of redirects to this page | 0 |
Page protection
Edit | Allow all users (infinite) |
Move | Allow all users (infinite) |
Edit history
Page creator | Fuelcolumn71 (Talk | contribs) |
Date of page creation | 08:40, 23 April 2024 |
Latest editor | Fuelcolumn71 (Talk | contribs) |
Date of latest edit | 08:40, 23 April 2024 |
Total number of edits | 1 |
Total number of distinct authors | 1 |
Recent number of edits (within past 90 days) | 1 |
Recent number of distinct authors | 1 |